Evidence map›Paper›PMID 37219788›Full record

ArticleJournal of community health2023

Cancer Screening Experiences of Black Breast and Ovarian Cancer Patients and Family Members.

Abigail Rousseau, Kirsten A Riggan, Michele Halyard, Sarah E James, Marion Kelly, Daphne Phillips, Megan A Allyse

Open access · bronzeAbstract read
In one paragraph

Article in Journal of community health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Abigail RousseauBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.
Kirsten A RigganBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.
Michele HalyardDepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Sarah E JamesDepartment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Marion KellyCoalition of Blacks Against Breast Cancer, Phoenix, AZ, USA.
Daphne PhillipsDepartment of Speech Pathology, Mayo Clinic, Phoenix, AZ, USA.
Megan A AllyseBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA. Allyse.Megan@mayo.edu.ORCID 0000-0001-6136-9256
WinnMed · USMayo Clinic in Florida · USAdvisory Board Company (United States) · USJacksonville College · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2005 to 2026
$49.9M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI ELLEN L. GOODE · 2009 to 2026
$37.0M
NCATS NIH HHS UL1 TR002377NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA116201NCI NIH HHS P50 CA136393NIH HHS Mayo Clinic's Breast and Ovarian Specialized Program of Research Excellence (SPORE)/Women's Cancer Program Developmental Research Program award (Breast SPORE (P50 CA116201), the Ovarian SPORE (P50 CA136393) and Cancer Center Grant (P30 CA015083))
6 · The paper itself

Abstract

Black women experience disproportionate rates of advanced breast cancer diagnoses and mortality. Mammography is a proven and effective tool in early breast cancer detection and impacts patient outcomes. We interviewed Black women with a personal or family history of breast and/or ovarian cancer to understand their screening experiences and views. N = 61 individuals completed an interview. Interview transcripts were qualitatively analyzed for themes regarding clinical experiences, guideline adherence, and family sharing specific to Black women and their families. Most participants were college educated with active health insurance. Women in this cohort were knowledgeable about the benefits of mammography and described few barriers to adhering to annual mammogram guidelines. Some with first-degree family history were frustrated at insurance barriers to mammography before the age of 40. Participants were generally comfortable encouraging family and friends to receive mammograms and expressed a desire for a similar screening tool for ovarian cancer. However, they expressed concern that factors such as screening awareness and education, lack of insurance coverage, and other systematic barriers might prevent other Black women from receiving regular screening. Black women in this cohort reported high adherence to mammography guidelines, but expressed concern about cultural and financial barriers that may impact cancer screening access in the population more generally and contribute to disparities. Participants noted the importance of frank and open discussions of breast cancer screening in their families and community as a means of improving awareness.

Indexed as

Breast NeoplasmsOvarian NeoplasmsEarly Detection of CancerFamilyFemaleHumansMammographyMass Screeninghealth disparitiesmammogramsovarian cancerqualitative researchself-breast exams

Identifiers

PMID37219788
PMCPMC10203662
OpenAlexW4377564913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.